You are here : Home > News > Ingrilimine toxin: a potential bioactive compound?

Scientific result | Headlines | Diagnosis and innovative treatment

Ingrilimine, a toxin produced by phytoplankton, a potential bioactive compound?


​Researchers from DMTS in collaboration with the Pasteur Institute have discovered and characterized a new toxin, ingrilimine, produced by a phytoplankton micro-organism. Its unique properties regarding a key receptor in neurodegenerative and cancer processes pave the way for the design of new therapeutic strategies.

Published on 2 October 2026

Cyclic imine toxins are rapid-acting neurotoxins produced by dinoflagellates, unicellular eukaryotic micro-organisms, major components of phytoplankton. Under certain conditions where harmful algal blooms[1] develop, crustaceans, which feed by filtering phytoplankton, can accumulate these toxins and transmit them to humans. In 2020 and 2021, during an algal bloom dominated by Vulcanodinium rugosum, Senegalese fishermen developed severe acute dermatitis after handling fishing nets: they had been exposed to high levels of portimine A, a toxin produced by Vulcanodinium rugosum.​

Most cyclic imine toxins are powerful antagonists of muscular and neuronal nicotinic acetylcholine receptors, essential for example for muscle contraction and respiration. The human α7 receptor is indispensable for cellular proliferation and recent work identifies it as a potential target for treating certain cancers, notably lung cancer, and neurodegenerative diseases.

Researchers from LPEM (SIMoS / DMTS), in collaboration with the Pasteur Institute, report the discovery of ingrilimine, a cyclic imine toxin purified from Vulcanodinium rugosum. The researchers determined its structure using various spectroscopic and spectrometric methods and showed that the toxin has powerful cytotoxic and pro-apoptotic activities against human cancer cell lines. They demonstrated a strong affinity of the toxin for the human α7 receptor, with the singularity of acting as an antagonist or agonist depending on its concentration.

Modeling the binding of ingrilimine to α7 allowed the prediction of interaction zones between the toxin and the transmembrane domain of the receptor, providing a better understanding of its antagonistic behavior. Electrophysiological experiments carried out on Xenopus oocytes overexpressing mutants of the α7 receptor clarify the essential role of a receptor residue in its activation by ingrilimine.

Overall, the unique properties of ingrilimine open perspectives for the design of therapies targeting α7 for both neurodegenerative diseases and certain cancers. This study reminds us that harmful algal blooms are neglected sources of bioactive compounds with original skeletons that can be used as leads for the treatment of human diseases.


Co​​ntact at the Frédéric-Joliot Institute for Life Sciences​​:

Rómulo A​ráoz (romulo.araoz@cea.fr) 

​​[1] Harmful algal blooms reach cell densities of 100,000 to 1,000,000 cells/mL, covering vast water surfaces that can be monitored by satellite.

Top page